|
Atomistry » Chlorine » PDB 8q5k-8qjt » 8qdc | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Chlorine » PDB 8q5k-8qjt » 8qdc » |
Chlorine in PDB 8qdc: Crystal Structure of Sars-Cov-2 Main Protease (Mpro) in Complex with the Covalent Inhibitor Gue-3642 (Compound 1 in Publication)Enzymatic activity of Crystal Structure of Sars-Cov-2 Main Protease (Mpro) in Complex with the Covalent Inhibitor Gue-3642 (Compound 1 in Publication)
All present enzymatic activity of Crystal Structure of Sars-Cov-2 Main Protease (Mpro) in Complex with the Covalent Inhibitor Gue-3642 (Compound 1 in Publication):
3.4.22.69; Protein crystallography data
The structure of Crystal Structure of Sars-Cov-2 Main Protease (Mpro) in Complex with the Covalent Inhibitor Gue-3642 (Compound 1 in Publication), PDB code: 8qdc
was solved by
N.Strater,
T.Claff,
K.Sylvester,
C.E.Mueller,
M.Guetschow,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of Sars-Cov-2 Main Protease (Mpro) in Complex with the Covalent Inhibitor Gue-3642 (Compound 1 in Publication)
(pdb code 8qdc). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of Sars-Cov-2 Main Protease (Mpro) in Complex with the Covalent Inhibitor Gue-3642 (Compound 1 in Publication), PDB code: 8qdc: Chlorine binding site 1 out of 1 in 8qdcGo back to![]() ![]()
Chlorine binding site 1 out
of 1 in the Crystal Structure of Sars-Cov-2 Main Protease (Mpro) in Complex with the Covalent Inhibitor Gue-3642 (Compound 1 in Publication)
![]() Mono view ![]() Stereo pair view
Reference:
R.Voget,
J.Breidenbach,
T.Claff,
A.Hingst,
K.Sylvester,
C.Steinebach,
L.P.Vu,
R.H.Weisse,
U.Bartz,
N.Strater,
C.E.Muller,
M.Gutschow.
Development of An Active-Site Titrant For Sars-Cov-2 Main Protease As An Indispensable Tool For Evaluating Enzyme Kinetics. Acta Pharm Sin B V. 14 2349 2024.
Page generated: Sun Jul 13 13:30:26 2025
ISSN: ISSN 2211-3835 PubMed: 38799620 DOI: 10.1016/J.APSB.2024.03.001 |
Last articlesFe in 2YXOFe in 2YRS Fe in 2YXC Fe in 2YNM Fe in 2YVJ Fe in 2YP1 Fe in 2YU2 Fe in 2YU1 Fe in 2YQB Fe in 2YOO |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |